FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2541300034> ?p ?o ?g. }

• W2541300034 abstract "Abstract Noonan syndrome (NS) is an autosomal dominant disorder characterized by variable expression of multiple defects including short stature, facial dysmorphias, congenital heart defects, developmental delay, and hematological abnormalities. A bleeding tendency has been variably described in patients with NS; Factor XI deficiency and platelet function abnormalities are reported most frequently. Recently, germline missense mutations in the PTPN11 gene have been identified in up to 50% of individuals with NS. PTPN11 encodes the ubiquitously expressed cell-signaling mediator SHP-2, a non-transmembrane protein tyrosine phosphatase involved in the normal activation of the Ras-MAPK signaling cascade. SHP-2 has a pivotal role in cell proliferation, differentiation, and survival, but also modulates platelet responses to some stimuli. Some PTPN11 mutations lead to altered SHP-2 phosphatase activity, and have been shown to impact cardiac development in a mouse model of NS. This study examined the potential association among PTPN11 mutations, platelet function abnormalities, and platelet SHP-2 activity in patients with NS. Eighteen patients with a clinical diagnosis of NS were studied: 14 (78%) were female and the mean age was 20.7 years (range 4–56 years). A validated bleeding questionnaire was administered to each participant, and platelet aggregometry was performed on platelet-rich plasma according to standard clinical practice. SHP-2 was isolated by immunoprecipitation from agoniststimulated platelets and phosphatase activity measured spectrophotometrically. PTPN11 mutations were identified by dHPLC and defined by DNA sequencing in each participant to characterize the presence and the precise nature of a mutation associated with their NS. Seven (39%) participants were classified as bleeders on the basis of the questionnaire; of these, four had no hemostasis abnormality identified. One participant had mild Factor XI deficiency. Seven participants had abnormalities of platelet aggregation, and four participants had decreased platelet dense granule numbers and ATP release. PTPN11 mutations were identified in 12 (67%) participants: seven were the commonly described mutation in Exon 8; four members of a three-generation family had a previously described Exon 3 mutation; and one individual had a mutation in Exon 12 which is usually associated with LEOPARD syndrome. Mutations in other genes associated with NS were not evaluated in this study. Six patients with PTPN11 mutations were clinically classified as bleeders, but no correlation was found between PTPN11 mutation and agonist-induced platelet aggregation or SHP-2 phosphatase activity. Three patients with platelet function abnormalities had no PTPN11 mutation identified. Not all patients with NS have a clinical bleeding profile or platelet function abnormalities. Neither clinical bleeding history nor platelet function abnormalities correlated with PTPN11 mutations, suggesting that additional factors may be required for a bleeding phenotype associated with PTPN11 mutations. Mutations in other NS-associated genes may contribute to a bleeding phenotype. Abnormalities in platelet aggregometry could not be explained on the basis of SHP-2 activity, although it is possible that changes in enzyme activity downstream in the Ras-MAPK pathway may impact platelet function in some patients with NS. Ultimately, the identification of a molecular basis for the frequently observed platelet aggregation defects could provide a means to predict the risk of bleeding in patients with NS." @default.
• W2541300034 created "2016-11-04" @default.
• W2541300034 creator A5018837258 @default.
• W2541300034 creator A5060455352 @default.
• W2541300034 creator A5061638311 @default.
• W2541300034 creator A5070463108 @default.
• W2541300034 creator A5076330302 @default.
• W2541300034 date "2008-11-16" @default.
• W2541300034 modified "2023-10-01" @default.
• W2541300034 title "The Association Between SHP-2 Mutations and Platelet Function in Noonan Syndrome." @default.
• W2541300034 doi "https://doi.org/10.1182/blood.v112.11.1239.1239" @default.
• W2541300034 hasPublicationYear "2008" @default.
• W2541300034 type Work @default.
• W2541300034 sameAs 2541300034 @default.
• W2541300034 citedByCount "1" @default.
• W2541300034 countsByYear W25413000342020 @default.
• W2541300034 crossrefType "journal-article" @default.
• W2541300034 hasAuthorship W2541300034A5018837258 @default.
• W2541300034 hasAuthorship W2541300034A5060455352 @default.
• W2541300034 hasAuthorship W2541300034A5061638311 @default.
• W2541300034 hasAuthorship W2541300034A5070463108 @default.
• W2541300034 hasAuthorship W2541300034A5076330302 @default.
• W2541300034 hasConcept C104317684 @default.
• W2541300034 hasConcept C126322002 @default.
• W2541300034 hasConcept C134018914 @default.
• W2541300034 hasConcept C170493617 @default.
• W2541300034 hasConcept C2776149932 @default.
• W2541300034 hasConcept C2781187634 @default.
• W2541300034 hasConcept C2910090564 @default.
• W2541300034 hasConcept C31734879 @default.
• W2541300034 hasConcept C501734568 @default.
• W2541300034 hasConcept C502942594 @default.
• W2541300034 hasConcept C54355233 @default.
• W2541300034 hasConcept C71924100 @default.
• W2541300034 hasConcept C75563809 @default.
• W2541300034 hasConcept C85528070 @default.
• W2541300034 hasConcept C86803240 @default.
• W2541300034 hasConcept C89560881 @default.
• W2541300034 hasConceptScore W2541300034C104317684 @default.
• W2541300034 hasConceptScore W2541300034C126322002 @default.
• W2541300034 hasConceptScore W2541300034C134018914 @default.
• W2541300034 hasConceptScore W2541300034C170493617 @default.
• W2541300034 hasConceptScore W2541300034C2776149932 @default.
• W2541300034 hasConceptScore W2541300034C2781187634 @default.
• W2541300034 hasConceptScore W2541300034C2910090564 @default.
• W2541300034 hasConceptScore W2541300034C31734879 @default.
• W2541300034 hasConceptScore W2541300034C501734568 @default.
• W2541300034 hasConceptScore W2541300034C502942594 @default.
• W2541300034 hasConceptScore W2541300034C54355233 @default.
• W2541300034 hasConceptScore W2541300034C71924100 @default.
• W2541300034 hasConceptScore W2541300034C75563809 @default.
• W2541300034 hasConceptScore W2541300034C85528070 @default.
• W2541300034 hasConceptScore W2541300034C86803240 @default.
• W2541300034 hasConceptScore W2541300034C89560881 @default.
• W2541300034 hasLocation W25413000341 @default.
• W2541300034 hasOpenAccess W2541300034 @default.
• W2541300034 hasPrimaryLocation W25413000341 @default.
• W2541300034 hasRelatedWork W165637066 @default.
• W2541300034 hasRelatedWork W1879519963 @default.
• W2541300034 hasRelatedWork W2011446963 @default.
• W2541300034 hasRelatedWork W2051721672 @default.
• W2541300034 hasRelatedWork W2051832425 @default.
• W2541300034 hasRelatedWork W2121052402 @default.
• W2541300034 hasRelatedWork W2121195198 @default.
• W2541300034 hasRelatedWork W2146167386 @default.
• W2541300034 hasRelatedWork W2163194943 @default.
• W2541300034 hasRelatedWork W2461374006 @default.
• W2541300034 hasRelatedWork W2519670344 @default.
• W2541300034 hasRelatedWork W2526857744 @default.
• W2541300034 hasRelatedWork W2534884722 @default.
• W2541300034 hasRelatedWork W2549164273 @default.
• W2541300034 hasRelatedWork W2558773773 @default.
• W2541300034 hasRelatedWork W2607043887 @default.
• W2541300034 hasRelatedWork W2627358092 @default.
• W2541300034 hasRelatedWork W2979561552 @default.
• W2541300034 hasRelatedWork W3041376033 @default.
• W2541300034 hasRelatedWork W2475511836 @default.
• W2541300034 isParatext "false" @default.
• W2541300034 isRetracted "false" @default.
• W2541300034 magId "2541300034" @default.
• W2541300034 workType "article" @default.